LGVN
Longeveron Inc.
$0.70
-$0.02 (-2.59%)Today
Key Statistics
Market cap22.03M
Price-Earnings ratio-0.46
Dividend yield—
Average volume220.91K
High today$0.71
Low today$0.69
Open price$0.70
Volume126.12K
52 Week high$1.80
52 Week low$0.47
Longeveron Inc.
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.